Objective: To study and explore the clinical efficacy of insulin intensive therapy on newly diagnosed type 2 diabetes mellitus and its effect on pancreatic β-cell function.Methods: One hundred patients with newly diagnosed type 2 diabetes treated in our hospital were included in this study. By using computer single-blind grouping method the patients were randomly divided into control group and observation group with 50 in each group. The control group was treated with oral metformin, while the observation group was treated with insulin intensive therapy. The blood glucose, insulin resistance index, islet β cell function index and hypoglycemia incidence were compared between the two groups. Results: After treatment, the fasting blood glucose, 2 h postprandial blood glucose and glycosylated hemoglobin in the observation group were significantly lower than those before treatment(P<0.05) and those in the control group after treatment (P<0.05). The insulin resistance index of the two groups decreased obviously(P<0.05), and the islet β cell function index was significantly increased(P<0.05). After treatment insulin resistance index in the observation group was significantly lower than that in the control group and β cell function index was significantly higher, the difference being statistically significant(P<0.05).Conclusion: The intensive insulin treatment can improve the blood glucose level and reduce the insulin resistance in patients with type 2 diabetes mellitus. It is helpful to repair the islet β cell function and is safe and reliable. |